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Protease-resistant prion protein (PrpSc) has been
identified as the infectious agent in a group of
neurodegenerative diseases called transmissible
spongiform encephalopathies (TSEs) or prion diseases
(1). One of the TSEs, Creutzfeldt-Jakob disease (CJD), is
of particular interest, because it has been the cause of a
food-originated epidemic in Europe. CJD was formerly
described as a sporadic or iatrogenic disease and its
interspecies transmissibility was known to be limited due
to the species barrier (2). However, this new variant
form of CJD (nvCJD) seems to be easily transmissible
from cattle, to humans through the diet; therefore
extensive research has been going on to define the
structure, toxicity and propagation mechanism of this
infectious agent.
The infectious PrpSc protein has a normal cellular
counterpart, PrpC, which is a sialoglycoprotein anchored
to
the
cellular
membrane
through
a
glycosylphosphatidylinositol moiety (3). The dominant
secondary structure of PrpC is α-helix, whereas PrpSc is
rich in β-sheet (4). In fact, there is no difference between
the primary structures of PrpC and PrpSc, and transgenic
mice devoid of normal PrpC are resistant to infection with
PrpSc. Therefore, it has been proposed that PrpSc behaves
as a template that promotes the conformational
transition of PrpC to PrpSc (1-4). Thus, prion diseases are
mainly considered protein folding disorders.
PrpSc is detergent insoluble, resistant to proteolytic
digestion and has a very high tendency to aggregate.
Pathologic changes that occur in the brain due to the
accumulation of PrpSc are florid plaques surrounded by
spongiform change, neuronal loss and astrocytosis (5).
Different hypotheses have been proposed to explain the
neurodegenerative effects of PrpSc. Data suggest the
involvement of transition metals in the mechanism but
the functional consequences of the interaction of PrpSc
with metals are still debated. The N-terminal domain of

the prion protein includes octapeptide motifs whose
general sequence is P(H/G)GG(G/S)WGQ and these motifs
+2
C
are involved in copper (Cu ) binding (6). Prp contains
+2
four Cu ions coordinated with four histidine imidazol
nitrogens (7). Recent data indicate that only two of these
Cu+2 ions are bound with an affinity similar to other
+2
authentic cuproproteins (8). Cu binding has been shown
to have diverse effects on PrpC. It has been shown to
stimulate the endocytosis of the prion protein from the
cell surface of neuroblastoma cells (9). Cu+2 also causes
PrpC to assume a protease-resistant and detergentinsoluble form (10). This species of prion protein is
similar to PrpSc, but its conformation is different (6,10).
Moreover, the addition of Cu+2 facilitates the renaturation
of denatured PrpSc, restoring its protease resistance and
infectivity (11). The metal binding property of the prion
protein seems to be important in understanding the
function of PrpC. Metal binding proteins are usually
implicated in the oxidative metabolism of cells and
oxidative stress is involved in a variety of
neurodegenerative diseases (12). By using infected cell
lines, it has been shown that infection with PrpSc impaired
the defense of the cell against oxidative stress (13). In a
similar study, neurons that were devoid of normal prion
protein showed lower glutathione reductase activity and
increased susceptibility to hydrogen peroxide toxicity
(14). It has also been proposed that PrpSc increased the
incorporation of Cu+2 into the Cu/Zn superoxide
dismutase (SOD) and it even had an activity like that of
SOD (15). The presence of Cu+2 ions renders the prion
protein susceptible to metal-catalyzed oxidation, and the
oxidation is accompanied by extensive aggregation and
precipitation of the protein (16).
In an attempt to identify the smallest fragment of
PrpSc that can be infectious and neurotoxic, a fragment
corresponding to residues 106-126 of human PrpC
(PrP106-126) has been identified (17-19). This sequence
corresponds to a highly conserved region of the protein
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and is susceptible to conformational transition. It is
capable of aggregating into amyloid-like fibrils and has a
tendency to take a β-sheet structure (17). Prp106-126
has been shown to exert a neurotoxic effect in a number
of cultured nerve cells by inducing apoptosis (18,19). It
also inhibits the function of PrpC through binding to it
(20) and this inhibition prevents the uptake of copper
into cells and the SOD-like activity of PrpC.
In the last 20 years, a growing body of information
has been accumulated in the field of prion research. There
is no doubt that the infectious agent is a misfolded

protein, and it is capable of converting normal prion
protein molecules into infectious ones. However, the
molecular details of the mechanism remain to be
elucidated. It is interesting to note that the implication of
Cu+2 ions in the formation of spongiform
encephalopathies was proposed about 30 years ago (21).
Recent findings also indicate the role of metal ions in the
mechanism and provide new pieces for the puzzle.
However, further research is necessary for us to be able
to see the whole picture.

References
1.

Cohen, F.E.: Protein misfolding and prion diseases. J. Mol. Biol.,
1999; 293: 313-320.

2.

Baldwin, M.A., Cohen, F.E., Prusiner, S.B.: Prion protein isoforms,
a convergence of biological and structural investigations. J. Biol.
Chem., 1995; 270: 19197-19200.

3.

Jackson, G.S., Collinge, J.: Prion disease-the propagation of
infectious protein topologies. Microbes. Infect., 2000; 2: 14451449.

4.

Cohen, F.E., Prusiner, S.B.: Pathologic conformations of prion
proteins. Ann. Rev. Biochem., 1998; 67: 793-819.

5.

Ironside, J.W., Head, M.W., Bell, J.E., McArdle, L., Will, R.G.:
Laboratory diagnosis of variant Creutzfeldt-Jakob disease.
Histopathology 2000; 37: 1-9.

6.

Quaglio, E., Chiesa, R., Harris, D.A.: Copper converts the cellular
prion protein into a protease resistant species that is distinct from
the scrapie isoform. J. Biol. Chem., 2001; 276: 11432-11438.

7.

Viles, J.H., Cohen, F.E., Prusiner, S.B., Goodin, D.B., Wright, P.E.,
Dyson, H.J.: Copper binding to the prion protein: structural
implications of four identical cooperative binding sites. Proc. Natl.
Acad. Sci. USA, 1999; 96: 2024-2047.

8.

9.
10.

Jackson, G.S., Murray, I., Hosszu, L.L.P., Gibbs, N., Waltho, J.P.,
Clarke, A.R., Collinge, J.: Location and properties of metal-binding
sites on the human prion protein. Proc. Natl. Acad. Sci. USA,
2001; 98: 8531-8535.
Pauly, P.C., Harris, D.A.: Copper stimulates endocytosis of the
prion protein. J. Biol. Chem., 1998; 273: 33107-33110.
Qin, K., Yang, D.S., Yang, Y., Chishti, M.A., Meng, L.J.,
Kretzschmar, H.A., Yip, C.M., Fraser, P.E., Westaway, D.:
Copper(II)-induced conformational changes and protease
resistance in recombinant and cellular PrP. J. Biol. Chem., 2000;
275: 19121-19131.

11.

McKenzie, D., Bartz, J., Mirwald, J., Olander, D., Marsh, R.,
Aiken, J.: Reversibility of scrapie inactivation is enhanced by
copper. J. Biol. Chem., 1998; 273: 25545-25547.

12.

Keller, J.N., Mattson, M.P.: Roles of lipid peroxidation in
modulation of cellular signaling pathways, cell dysfunction, and
death in the nervous system. Rev. Neurosci., 1998; 9: 105-116.

1206

13.

Milhavet, O., McMahon, H.E.M., Rachidi, W., Nishida, N.,
Katamine, S., Mangé, A., Arlotto, M., Casanova, D., Riondel, J.,
Favier, A., Lehmann, S.: Prion infection impairs the cellular
response to oxidative stress. Proc. Natl. Acad. Sci. USA, 2000; 97:
13937-13942.

14.

White, A.R., Collins, S.J., Maher, F., Jobling, M.F., Stewart, L.R.,
Thyer, J.M., Beyreuther, K., Masters, C.L., Cappai, R.: Prion
protein-deficient neurons reveal lower glutathione reductase
activity and increased susceptibility to hydrogen peroxide toxicity.
Am. J. Pathol., 1999; 155: 1723-1730.

15.

Brown, D.R., Wong, B.S., Hafiz, F., Clive, C., Haswell, S.J., Jones,
I.M.: Normal prion protein has an activity like that of superoxide
dismutase. Biochem. J., 1999; 344: 1-5.

16.

Requena, J.R., Groth, D., Legname, G., Stadtman, E.R., Prusiner,
S.B., Levine, R.L.: Copper-catalyzed oxidation of the recombinant
Sha(29-231) prion protein. Proc. Natl. Acad. Sci. USA, 2001; 98:
7170-7175.

17.

Tagliavini, F., Prelli, F., Verga, L., Giaccone, G., Sarma, R.,
Gorevic, P., Ghetti, B., Passerini, F., Ghibaudi, E., Forloni, G.,
Salmona, M., Bugiani, O., Frangione, B.: Synthetic peptides
homologous to prion protein residues 106-147 form amyloid-like
fibrils in vitro. Proc. Natl. Acad. Sci. USA, 1993; 90: 9678-9682.

18.

Ettaiche, M., Pichot, R., Vincent, J.P., Chabry, J.: In vivo
cytotoxicity of the prion protein fragment 106-126. J. Biol.
Chem., 2000; 275: 36487-36490.

19.

O’Donovan, C.N., Tobin, D., Cotter, T.G.: Prion protein fragment
PrP106-216 induces apoptosis via mitochondrial disruption in a
human neuronal SH-SY5Y cells. J. Biol. Chem., 2001; in press.

20.

Brown, D.R.: PrPSc-like prion protein peptide inhibits the function
of cellular prion protein. Biochem. J., 2001; 352: 511-518.

21.

Pattison, I.H., Jebbett, J.N.: Histopathological similarities between
scrapie and cuprizone toxicity in mice. Nature., 1971; 230: 115117.

